Drew Muscara

Trialtrove Analyst, Citeline

Drew currently supports clinical trial intelligence for the cardiometabolic, vaccine, infectious disease, and genitourinary therapy areas at Citeline. He excels in conducting in-depth data analyses for a variety of applications and utilizes these methods in constructing detailed Ask the Analyst responses. Additionally, through his membership on our analyst bench team, Drew has assisted on a variety of bespoke consulting projects to serve clients.

Prior to joining Citeline in 2021, he also conducted research in immunology, lupus, and cell apoptosis. The study focused on determining relative gene expression in cell culture derived from animals that had contracted lupus.